Key facts
- It has raised $13.0M; the latest was Seed Round ($3.0M) in Jun 2025.
- Notable investors include Sanfer Laboratories.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Medsi
- ·The full record, as it builds
Funding rounds
No funding rounds for Medsi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medsi
Developer of a medical-grade artificial intelligence (AI) platform designed to enable preventive healthcare through personalized, remote monitoring and early detection of chronic diseases. The company offers real-time vital sign tracking, behavioral science-based treatment guidance, and automated health risk analysis, enabling employers, patients, healthcare providers, and public agencies to improve long-term health outcomes and reduce the burden of non-communicable diseases.
- Sector
- Healthcare
- HQ
- Mexico City, Mexico
- Founded
- 2021
- Website
- medsi.ai/
- Ownership
- Privately Held (backing)
Medsi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medsi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medsi in its N-PORT filings yet. We sweep new filings monthly.